Zentalis Pharmaceuticals, Inc. SEC filings ZNTL
Zentalis Pharmaceuticals, Inc. has 546 filings in SEC EDGAR's recent list, going back to Dec 19, 2017. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 4, 2025 | — |
| CORRESP | Letter to the SEC | Apr 2, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2024 | — |
| CORRESP | Letter to the SEC | Oct 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2022 | — |
| CORRESP | Letter to the SEC | Jun 22, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | May 26, 2022 | — |
| UPLOAD | Letter from the SEC | May 12, 2022 | — |
| RW | Filing | May 4, 2021 | — |
| EFFECT | Filing | Jul 29, 2020 | — |
| CORRESP | Letter to the SEC | Jul 27, 2020 | — |
| CORRESP | Letter to the SEC | Jul 27, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2020 | — |
| DRS | Filing | Jul 10, 2020 | — |
| SEC STAFF LETTER | Filing | Apr 6, 2020 | — |
| CERT | 8a cert | Apr 3, 2020 | — |
| EFFECT | Filing | Apr 2, 2020 | — |
| 8-A12B | Filing | Apr 2, 2020 | — |
| CORRESP | Letter to the SEC | Mar 31, 2020 | — |
| CORRESP | Letter to the SEC | Mar 31, 2020 | — |
| CORRESP | Letter to the SEC | Mar 13, 2020 | — |
| CORRESP | Letter to the SEC | Mar 13, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 21, 2020 | — |
| DRSLTR | Filing | Feb 14, 2020 | — |
| DRS/A | Filing | Feb 14, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2020 | — |
| DRS | Filing | Jan 8, 2020 | — |
| D | Filing | Sep 5, 2019 | — |
| D | Filing | Dec 19, 2017 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZNTL (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1725160
- Former names
- Zentalis Pharmaceuticals, LLC (until Apr 6, 2020); Zeno Pharma, LLC (until Sep 5, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.